These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 685753)
1. The role of platelets in transient ischemic attacks and cerebral vascular accidents. Barnett HJ Adv Exp Med Biol; 1978; 102():257-63. PubMed ID: 685753 [TBL] [Abstract][Full Text] [Related]
2. Summary of design features: clinical trials of platelet-active drugs in cerebrovascular disease. Friedman LM Circulation; 1980 Dec; 62(6 Pt 2):V88-9. PubMed ID: 7002355 [TBL] [Abstract][Full Text] [Related]
3. Proceedings: The effect of a platelet inhibiting drug (sulfinpyrazone) in the therapy of patients with transient ischemic attacks (Tia's) and minor strokes. Robertson JT; Dugdale M; Salky N; Robinson H Thromb Diath Haemorrh; 1975 Nov; 34(2):598. PubMed ID: 1105880 [No Abstract] [Full Text] [Related]
4. The Canadian trial of aspirin and sulfinpyrazone in threatened stroke. Whisnant JP Am Heart J; 1980 Jan; 99(1):129-30. PubMed ID: 6985763 [No Abstract] [Full Text] [Related]
5. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. Canadian Cooperative Study Group N Engl J Med; 1978 Jul; 299(2):53-9. PubMed ID: 351394 [TBL] [Abstract][Full Text] [Related]
6. Guidelines for the management of transient ischemic attacks. Sandok BA; Furlan AJ; Whisnant JP; Sundt TM Mayo Clin Proc; 1978 Oct; 53(10):665-74. PubMed ID: 362079 [TBL] [Abstract][Full Text] [Related]
7. Aspirin in transient ischemic attacks and minor stroke: a meta-analysis. Stachenko SJ; Bravo G; Côté R; Boucher J; Battista RN Fam Pract Res J; 1991 Jun; 11(2):179-91. PubMed ID: 1829313 [TBL] [Abstract][Full Text] [Related]
8. A randomized trial of aspirin and sulfinpyrazone in patients with threatened stroke. Results and methodologic issues. Gent M; Barnett HJ; Sackett DL; Taylor DW Circulation; 1980 Dec; 62(6 Pt 2):V97-105. PubMed ID: 7002357 [TBL] [Abstract][Full Text] [Related]
10. Controlled trial of aspirin in cerebral ischemia: an addendum. Lemak NA; Fields WS; Gary HE Neurology; 1986 May; 36(5):705-10. PubMed ID: 3517694 [TBL] [Abstract][Full Text] [Related]
11. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease. Genton E Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166 [No Abstract] [Full Text] [Related]
12. Placebo-controlled, double-blind clinical trials can impede medical progress. Ritter JM Lancet; 1980 May; 1(8178):1126-7. PubMed ID: 6103452 [No Abstract] [Full Text] [Related]
15. Aspirin to prevent a stroke? N Z Med J; 1978 Oct; 88(621):286-7. PubMed ID: 364347 [No Abstract] [Full Text] [Related]
16. Platelets, carotids, and coronaries. Critique on antithrombotic role of antiplatelet agents, exercise, and certain diets. Eichner ER Am J Med; 1984 Sep; 77(3):513-23. PubMed ID: 6383036 [TBL] [Abstract][Full Text] [Related]
17. Does aspirin prevent stroke? Mitchell JR Practitioner; 1979 Nov; 223(1337):668-72. PubMed ID: 394138 [No Abstract] [Full Text] [Related]
18. A randomized trial of aspirin and sulfinpyrazone in patients with TIA. Candelise L; Landi G; Perrone P; Bracchi M; Brambilla G Stroke; 1982; 13(2):175-9. PubMed ID: 7039004 [TBL] [Abstract][Full Text] [Related]
19. Effect of sulfinpyrazone on platelet survival time in patients with transient cerebral ischemic attacks. Steele P; Carroll J; Overfield D; Genton E Stroke; 1977; 8(3):396-8. PubMed ID: 871029 [TBL] [Abstract][Full Text] [Related]
20. Therapy of ischemic cerebral vascular disease due to atherothrombosis. (2). Kistler JP; Ropper AH; Heros RC N Engl J Med; 1984 Jul; 311(2):100-5. PubMed ID: 6377062 [No Abstract] [Full Text] [Related] [Next] [New Search]